Award
National Cancer Institute 5F30CA257622-03
Neoantigen-specific T cells in a novel cutaneous squamous cell carcinoma model
Recipient
University of Arizona
Award Amount
$54,538.00
Ceiling
$54,538.00
Awarded
July 03, 2025
Identifier
5F30CA257622-03
Award to University of Arizona by National Cancer Institute for research on neoantigen-specific T cells in cutaneous squamous cell carcinoma, funded at $54,538 for 2025.
Description
The project focuses on understanding the role of neoantigen-specific T cells in controlling cutaneous squamous cell carcinoma (cSCC) using a novel murine model. The project aims to identify MHC class I and II neoantigens that elicit T cell responses and evaluate vaccination strategies in combination with anti-PD-1 therapy. The research is conducted by the University of Arizona, Tucson, AZ. The project is funded by the National Cancer Institute, with a total budget of $54,538 for the fiscal year 2025. The project duration is from August 1, 2023, to July 31, 2026.